Skip to main content

Home/ Dr. Goodyear/ Contents contributed and discussions participated by Nathan Goodyear

Contents contributed and discussions participated by Nathan Goodyear

Nathan Goodyear

Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinar... - 0 views

  •  
    good discussion of cortisol metabolite excretion in children.
Nathan Goodyear

Prevalence of erectile dysfunction... [Eur Rev Med Pharmacol Sci. 2014] - PubMed - NCBI - 0 views

  •  
    ED in type II diabetics with low Testosterone is almost a given.
Nathan Goodyear

Testosterone levels increase in association w... [Osteoporos Int. 2014] - PubMed - NCBI - 0 views

  •  
    Study finds that low Testosterone (43% of men) in early fractures is more of an effect of the stress associated with the event than low T itself.  The authors of this study point to additional evaluation delayed from event to provide additional support to the low T diagnosis and therapy.
Nathan Goodyear

Short-term testosterone therapy failed to increase CV risk in women | Endocrinology - 0 views

  •  
    24 week study of 71 women post-hysterectomy finds no increase in cardiovascular biomarkers.  Several problems with this study.  First, there was a large drop out--24%.  Second and most important, the women were pretreated with estrogen prior to Testosterone therapies were initiated.  Other studies have proposed that this protects cardiovascular risk in women on Testosterone.  Previous studies show increasing endogenous Testosterone is associated with increasing cardiovascular disease in women.   This study would be much better if no estradiol was prescribed.  That would give an unbiased view of Testosterone in post-hysterectomy women.  Not much can be taken from this study. If you doctor doesn't know this, find another doctor.  Inherent bias in this study as ties to the manufacturer of the Testosterone was disclosed. This study point to the inherent flaws in so much of the medical literature today.  Most would read the headlines and read no further, but the "further" dispels the headline as flawed.
Nathan Goodyear

Differential pathways regulating innate and adaptive antitumor immune respons... - 0 views

  •  
    beta glucans stimulate both innate and adaptive immune system to attack tumor cells.
Nathan Goodyear

Orally Administered Particular β-Glucan Modulates Tumor-capturing Dendritic C... - 0 views

  •  
    Beta glucans have both an innate and adaptive effect to enhance the environment in/and around tumor.  Beta glucans stimulate the immune system signaling to attack tumors.
Nathan Goodyear

The effects of β-glucans on dendr... [Anticancer Agents Med Chem. 2013] - Pub... - 0 views

  •  
    Beta-glucans stimulate NK cells through TH1 stimulation.  This provides the immune enhancing effect that attacks cancer cells.
Nathan Goodyear

Immune modulating effects of ... [Curr Opin Clin Nutr Metab Care. 2010] - PubMed - NCBI - 0 views

  •  
    Beta-glucans stimulate immune activity and thus their benefit in cancer.
Nathan Goodyear

The effects of β-glucan on human immune and cancer cells - 0 views

  •  
    Beta-glucan's effect on the immune system and cancer.
Nathan Goodyear

http://partnecglobal.eurasiansupply.com/ds/rd/rdgf/_pdf7.pdf - 0 views

  •  
    Study finds that maitake mushroom extract, MD-Fraction (a beta-glucan), has significant anti-tumor activity and anti-metastasis activity through NK activity, Antigen presenting cells, and through suppression of ICAM-1.
Nathan Goodyear

Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushro... - 0 views

  •  
    This was an in vitro study of Maitake mushrooms and prostate cancer.  They found that the beta-glucan stimulated apoptosis of the cancer cells.  The study also found that vitamin C potentiated this kill effect.
Nathan Goodyear

Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola fr... - 0 views

  •  
    The D-Fraction from maitake mushrooms enhanced the cytotoxicity from NK cells through IL-12 signaling.
Nathan Goodyear

Questions and answers on the role of faecal calprotectin as a biological marker in infl... - 0 views

  •  
    Calprotectin is a useful biomarker in IBD.  Colorectal cancer and GI infection can also increase fecal Calprotectin. 
Nathan Goodyear

Fecal Calprotectin: Validation as a Noninvasive Measure of B... : Journal of Pediatric ... - 0 views

  •  
    fecal Calprotectin validated in the measure of IBD in children.
Nathan Goodyear

Role of faecal calprotectin as non-invasive marker of intestinal inflammation - 0 views

  •  
    Calprotectin useful as a marker of intestinal inflammation.
Nathan Goodyear

American Journal of Gastroenterology - Abstract of article: Diagnostic Precision of Fec... - 0 views

  •  
    Fecal calprotectin is found to be a much better screening test for IBD than colorectal cancer.  Though, fecal Calprotectin levels were found to be elevated in colorectal cancer compared to controls, the sensitivity and specificity was low.  In contrast, a fecal Calprotectin > 100 mg/g, in this study, was found to be specific and sensitive for IBD and excluding IBS.
Nathan Goodyear

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in C... - 0 views

  •  
    Fecal Calprotectin found to be useful as monitor for Ulcerative colitis relapse.  This was found more specific for UC than Crohn's disease.  There was a 14 fold higher relapse risk in those with levels > 150.
Nathan Goodyear

Semen quality, infertility and mortality in the USA - 0 views

  •  
    Men with infertility associated with 2.3 fold higher risk of death. The factors evaluated were semen volume, sperm concentration, sperm motility, total sperm count, total motile sperm count.  Those that have 2 or more positive parameters were associated with increased death compared to those with normal semen analysis.
Nathan Goodyear

St. John's Wort Has Metabolically Favorable Effects on Adipocytes In Vivo - 0 views

  •  
    St john's wort increased insulin sensitivity and adiponectin on in vivo study.
Nathan Goodyear

Reduced testosterone levels indicate need to trea... [Nurs Stand. 2014] - PubMed - NCBI - 0 views

  •  
    I can only find the abstract of this article.  This article fits with the growing body of evidence that low Testosterone is a poor prognostic factor for men with prostate cancer.  This very short abstract points to using low levels of "free Testosterone" as a biomarker to treat low-risk prostate cancer.
« First ‹ Previous 6501 - 6520 of 10936 Next › Last »
Showing 20 items per page